Published in Gut on January 01, 2000
Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol (2006) 4.34
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ (2009) 2.51
Functional bowel disorders in adults. Dtsch Arztebl Int (2012) 2.38
A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut (2005) 2.11
The epidemiology of irritable bowel syndrome. Clin Epidemiol (2014) 2.06
Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract (2004) 2.03
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut (2015) 1.55
Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut (2002) 1.47
Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32
Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol (2009) 1.32
The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology. Crit Rev Environ Sci Technol (2015) 1.29
The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil (2010) 1.24
Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res (2011) 1.16
Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol (2010) 1.14
Brain-Gut Interactions in IBS. Front Pharmacol (2012) 1.10
Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol (2008) 1.06
Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial. Nutrients (2015) 1.04
Complementary and alternative medicine for treatment of irritable bowel syndrome. Can Fam Physician (2009) 1.02
Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1. Int J Prev Med (2012) 1.01
Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Br J Gen Pract (2006) 1.01
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Applying case definition criteria to irritable bowel syndrome. Clin Med Res (2008) 0.99
Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms. World J Gastroenterol (2010) 0.97
Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes (2006) 0.95
Predicting colorectal cancer risk in patients with rectal bleeding. Br J Gen Pract (2006) 0.95
Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur J Epidemiol (2007) 0.94
Treatments for irritable bowel syndrome: patients' attitudes and acceptability. BMC Complement Altern Med (2008) 0.94
Updates on treatment of irritable bowel syndrome. World J Gastroenterol (2008) 0.94
A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study. Br J Gen Pract (2004) 0.94
Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer (2011) 0.93
Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors. J Res Med Sci (2011) 0.92
Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients. J Gastroenterol (2009) 0.91
Functional findings in irritable bowel syndrome. World J Gastroenterol (2006) 0.89
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87
A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol (2013) 0.87
Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment. Pharmacoeconomics (2016) 0.87
The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study. PLoS One (2014) 0.86
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2014) 0.85
Prevalence of functional bowel disorders and faecal incontinence: an Australian primary care survey. Colorectal Dis (2015) 0.85
High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome. PLoS One (2011) 0.84
More negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS--a case-control study in primary care. BMC Fam Pract (2015) 0.83
Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. Evid Based Complement Alternat Med (2014) 0.83
Do published guidelines for evaluation of irritable bowel syndrome reflect practice? BMC Gastroenterol (2001) 0.83
Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome? World J Gastroenterol (2007) 0.83
Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study. PLoS One (2015) 0.83
The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study. Gut Liver (2011) 0.82
Pathophysiology and management of irritable bowel syndrome. Korean J Intern Med (2001) 0.81
Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol (2014) 0.81
Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link? Dig Dis Sci (2008) 0.81
Effects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study. Ann Med Health Sci Res (2013) 0.81
Relationship of bloating to other GI and menstrual symptoms in women with irritable bowel syndrome. Dig Dis Sci (2004) 0.78
IBS: prime problem in primary care. Gut (2000) 0.78
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? World J Gastroenterol (2007) 0.78
Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997. Dig Dis Sci (2002) 0.78
Treatment of Irritable Bowel Syndrome. Curr Treat Options Gastroenterol (2003) 0.78
Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.78
Sex and gender in irritable bowel syndrome. J Gastroenterol (2006) 0.78
Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis. Am J Gastroenterol (2016) 0.78
Irritable bowel syndrome: are complementary and alternative medicine treatments useful? Can Fam Physician (2009) 0.77
Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial. Middle East J Dig Dis (2015) 0.77
Abuse in women and men with and without functional gastrointestinal disorders. Dig Dis Sci (2007) 0.77
Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders. World J Gastrointest Pharmacol Ther (2010) 0.77
Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers. Gastroenterol Res Pract (2009) 0.77
Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract (2016) 0.76
An antiemetic for irritable bowel syndrome? J Fam Pract (2014) 0.75
Low prevalence of irritable bowel syndrome in primary health care in four Swedish counties. Scand J Prim Health Care (2013) 0.75
Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care. Frontline Gastroenterol (2016) 0.75
Evaluating a computer aid for assessing stomach symptoms (ECASS): study protocol for a randomised controlled trial. Trials (2016) 0.75
Using read codes to identify patients with irritable bowel syndrome in general practice: a database study. BMC Fam Pract (2013) 0.75
General practitioners believe that hypnotherapy could be a useful treatment for irritable bowel syndrome in primary care. BMC Fam Pract (2004) 0.75
Exploring the agreement between diagnostic criteria for IBS in primary care in Greece. BMC Res Notes (2008) 0.75
Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead? Therap Adv Gastroenterol (2009) 0.75
Uncomfortable implications: placebo equivalence in drug management of a functional illness. J Med Ethics (2007) 0.75
Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea. Biopsychosoc Med (2017) 0.75
Do gastrointestinal complaints increase the risk for subsequent medically certified long-term sickness absence? The HUSK study. BMC Gastroenterol (2011) 0.75
Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome? Am J Gastroenterol (2017) 0.75
Does coeliac disease affect colorectal practice? Int J Colorectal Dis (2006) 0.75
Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Towards positive diagnosis of the irritable bowel. Br Med J (1978) 12.79
Non-colonic features of irritable bowel syndrome. Gut (1986) 5.48
Opening Pandora's box: the unpredictability of reassurance by a normal test result. BMJ (1996) 4.16
A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology (1984) 2.70
Psychological significance of the irritable colon syndrome. Gut (1971) 2.58
Partial hospitalization: an update. Am J Psychiatry (1990) 2.24
Impact of irritable bowel syndrome on quality of life. Dig Dis Sci (1996) 1.81
Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract (1992) 1.75
Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician. Gastroenterology (1976) 1.61
A database on dyspepsia. Gut (1994) 1.41
Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol (1997) 1.32
Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut (1997) 1.31
Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry (1986) 1.09
Towards positive diagnosis of the irritable bowel. Br Med J (1978) 12.79
Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol (1997) 8.81
Functional bowel disorders in apparently healthy people. Gastroenterology (1980) 8.52
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Is extrinsic sugar a vehicle for dietary fat? Lancet (1995) 4.05
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun (1984) 3.63
Effects of increased dietary fibre on intestinal transit. Lancet (1973) 3.49
Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet (1977) 3.08
Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J (1979) 2.93
Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ (1990) 2.86
Perceptions and reactions of the public to diarrhoea. J R Soc Health (1993) 2.22
Increasing frequency of gall bladder operations in the Bristol clinical area. Br Med J (1972) 2.20
Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber) Gastroenterology (1992) 2.19
Gall stones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. Br Med J (1969) 2.17
The effect of wheat bran on intestinal transit. Gut (1975) 2.10
The importance of keeping bile salts in their place. Gut (1969) 2.08
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
The MD thesis in the training of a consultant physician. J R Coll Physicians Lond (1992) 2.03
Food fibre as an obstacle to energy intake. Lancet (1973) 1.87
The epidemiology of gallstones and suggested aetiology. Clin Gastroenterol (1973) 1.83
Variability of colonic function in healthy subjects. Gut (1978) 1.82
Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet (1977) 1.80
Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) (1985) 1.64
Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors. Gut (1986) 1.64
Gallbladder inertia and sluggish enterohepatic circulation of bile-salts in coeliac disease. Lancet (1971) 1.62
Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58
The effect of cholecystectomy on bile salt metabolism. Gut (1973) 1.56
The effect on intestinal transit and the feces of raw and cooked bran in different doses. Am J Clin Nutr (1976) 1.50
Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut (1994) 1.44
Bile salt metabolism in patients with gallstones in functioning gallbladders. Gut (1973) 1.39
Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J (1979) 1.39
Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab (1999) 1.36
The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients. Am J Dig Dis (1976) 1.36
Enterohepatic circulation of C14-labeled bile salts in disorders of the distal small bowel. Gastroenterology (1968) 1.36
The role of dietary fiber in satiety, glucose, and insulin: studies with fruit and fruit juice. Am J Clin Nutr (1981) 1.32
Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol (1997) 1.32
How trustworthy are bowel histories? Comparison of recalled and recorded information. Br Med J (1976) 1.29
Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up. Gut (1988) 1.26
Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med (2003) 1.26
Deoxycholic acid and the pathogenesis of gall stones. Gut (1988) 1.26
Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut (1997) 1.25
Miliary Crohn's disease. Gut (1967) 1.24
Diet and ulcerative colitis. Br Med J (1980) 1.20
Proctalgia fugax. J R Coll Physicians Lond (1980) 1.18
Secondary thyroidectomy: a twenty-year experience. World J Surg (1988) 1.16
Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor. Aliment Pharmacol Ther (2003) 1.16
Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A. J Gen Microbiol (1974) 1.14
Aetiology of acute appendicitis. Br Med J (Clin Res Ed) (1987) 1.14
Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile. Gut (1986) 1.14
Alteration of bile salt metabolism by dietary fibre (bran). Br Med J (1973) 1.13
Effect of bran on blood lipids and calcium. Lancet (1974) 1.13
A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. Br Med J (Clin Res Ed) (1981) 1.13
Lipid composition of bile in diabetics and obesity-matched controls. Gut (1979) 1.10
The effect of coeliac disease upon bile salts. Gut (1973) 1.08
"Rectal dissatisfaction" in the irritable bowel syndrome. A manometric and radiological study. Int J Colorectal Dis (1986) 1.07
Empyema of the gall bladder - reappraisal of a neglected disease. Gut (1983) 1.07
Pain measurement scales: a comparison of the visual analogue and faces rating scales in measuring pressure ulcer pain. J Wound Ostomy Continence Nurs (2001) 1.07
Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy. Br Med J (1966) 1.07
Estimation of cholesterol in bile: assessment of an enzymatic method. Clin Chim Acta (1980) 1.06
Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea. Gastroenterology (1972) 1.06
Final year medical students' knowledge of practical nutrition. J R Soc Med (1992) 1.05
Effects of fasting on the composition of gallbladder bile. Gut (1980) 1.05
Pruritic effect of bile salts. Br Med J (1974) 1.05
Bran and bile: time-course of changes in normal young men given a standard dose. Scand J Gastroenterol (1978) 1.04
Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. Br Med J (Clin Res Ed) (1981) 1.03
A simplified procedure for the analysis of cholesterol, phospholipids and bile salts in human bile. Clin Chim Acta (1978) 1.02
A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy. Br J Dermatol (1978) 1.02
Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut (1983) 1.02
A tripartite anoikis-like mechanism causes early isolated islet apoptosis. Surgery (2001) 1.02
Glucose and insulin responses to manufactured and whole-food snacks. Am J Clin Nutr (1987) 1.02
Disturbances of bile acid metabolism in intestinal disease. Clin Gastroenterol (1977) 1.01
Increased ratio of glycine- to taurine-conjugated bile salts in patients with ileal disorders. Gastroenterology (1969) 1.01
Ileal bile salt transport: mutual inhibition in an in vivo system. Am J Physiol (1968) 1.01
An in vivo comparison of two bile salt binding agents, cholestyramine and lignin. Scand J Gastroenterol (1971) 1.00
Intestinal transit time in the population calculated from self made observations of defecation. J Epidemiol Community Health (1993) 0.99
Gastric emptying of a solid meal is accelerated by the removal of dietary fibre naturally present in food. Gut (1995) 0.99
Bile salt metabolism and the colon. Scand J Gastroenterol (1973) 0.98
Fluctuations of serum and bile lipid concentrations during the menstrual cycle. Br Med J (1977) 0.98
Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment. Addiction (1999) 0.97
Some determinants of whole-gut transit time: a population-based study. QJM (1995) 0.96
Alcohol consumption and its relation to cardiovascular risk factors in British women. BMJ (1992) 0.94
The metabolic consequences of slow colonic transit. Am J Gastroenterol (1999) 0.93
Not just fibre--the nutritional consequences of refined carbohydrate foods. Hum Nutr Clin Nutr (1983) 0.93
Letter: Bran and the irritable bowel. Lancet (1976) 0.93
Mitogenicity of Naegleria fowleri extract for murine T lymphocytes. Immunology (1984) 0.92
Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. Surgery (2001) 0.92
Bile salt tests in clinical practice. Br Med J (1979) 0.90
Description of the Genetic Analysis Workshop 10 bipolar disorder linkage data sets. Genet Epidemiol (1997) 0.89
Acute respiratory distress secondary to Morgagni diaphragmatic herniation in an adult. Postgrad Med J (1995) 0.89
The Pittsburgh Sleep Quality Index (PSQI). J Gerontol Nurs (1999) 0.88
Roughage revisited: the effect on intestinal function of inert plastic particles of different sizes and shape. Dig Dis Sci (1999) 0.88
Functional diarrhoea: the acid test. Br Med J (Clin Res Ed) (1985) 0.88
Effects of dietary sucrose on factors influencing cholesterol gall stone formation. Gut (1984) 0.88
Letter: Effect of bran on blood-lipids. Lancet (1975) 0.88
Alcoholic liver disease. Br J Hosp Med (1977) 0.87
Erythropoietin and anemia of gastrointestinal bleeding in a Jehovah's Witness. Ann Intern Med (1990) 0.87
Absorption of bile acids by the colon. Gut (1970) 0.86